Literature DB >> 20804538

STAT3 modulates the DNA damage response pathway.

Seán P Barry1, Paul A Townsend, Richard A Knight, Tiziano M Scarabelli, David S Latchman, Anastasis Stephanou.   

Abstract

The STAT3 transcription factor is well known to function as an anti-apoptotic factor, especially in numerous malignancies. Recently we showed that STAT3 is cytoprotective and that cells lacking STAT3 are more sensitive to oxidative stress. A key feature of oxidative stress involves activation of the DNA damage pathway. However, a role for STAT3 or its contribution in response to DNA damage has not been described. In the present study we show that cells lacking STAT3 are less efficient in repairing damaged DNA. Moreover, STAT3 deficient cells show reduced activity of the ATM-Chk2 and ATR-Chk1 pathways, both important pathways in sensing DNA damage. Finally we show that MDC1, a regulator of the ATM-Chk2 pathway and facilitator of the DNA damage response, is modulated by STAT3 at the transcriptional level. These findings demonstrate that STAT3 is necessary for efficient repair of damaged DNA, partly by modulating the ATM-Chk2 and ATR-Chk1 pathways.
© 2010 The Authors. International Journal of Experimental Pathology © 2010 International Journal of Experimental Pathology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20804538      PMCID: PMC3010549          DOI: 10.1111/j.1365-2613.2010.00734.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  28 in total

1.  Genomic instability in mice lacking histone H2AX.

Authors:  Arkady Celeste; Simone Petersen; Peter J Romanienko; Oscar Fernandez-Capetillo; Hua Tang Chen; Olga A Sedelnikova; Bernardo Reina-San-Martin; Vincenzo Coppola; Eric Meffre; Michael J Difilippantonio; Christophe Redon; Duane R Pilch; Alexandru Olaru; Michael Eckhaus; R Daniel Camerini-Otero; Lino Tessarollo; Ferenc Livak; Katia Manova; William M Bonner; Michel C Nussenzweig; André Nussenzweig
Journal:  Science       Date:  2002-04-04       Impact factor: 47.728

2.  Rapid assessment of repair of ultraviolet DNA damage with a modified host-cell reactivation assay using a luciferase reporter gene and correlation with polymorphisms of DNA repair genes in normal human lymphocytes.

Authors:  Yawei Qiao; Margaret R Spitz; Zhaozheng Guo; Mohammad Hadeyati; Lawrence Grossman; Kenneth H Kraemer; Qingyi Wei
Journal:  Mutat Res       Date:  2002-11-30       Impact factor: 2.433

Review 3.  Stats: transcriptional control and biological impact.

Authors:  David E Levy; J E Darnell
Journal:  Nat Rev Mol Cell Biol       Date:  2002-09       Impact factor: 94.444

4.  Ischemia-induced STAT-1 expression and activation play a critical role in cardiomyocyte apoptosis.

Authors:  A Stephanou; B K Brar; T M Scarabelli; A K Jonassen; D M Yellon; M S Marber; R A Knight; D S Latchman
Journal:  J Biol Chem       Date:  2000-04-07       Impact factor: 5.157

5.  Deficiency in the repair of UV-induced DNA damage in human skin fibroblasts compromised for the ATM gene.

Authors:  Mohammed A Hannan; Ali Hellani; Fahad M Al-Khodairy; Mohammed Kunhi; Yunis Siddiqui; Noujud Al-Yussef; Nancy Pangue-Cruz; Monica Siewertsen; Mohammed N Al-Ahdal; Abdelilah Aboussekhra
Journal:  Carcinogenesis       Date:  2002-10       Impact factor: 4.944

Review 6.  STAT proteins: novel molecular targets for cancer drug discovery.

Authors:  J Turkson; R Jove
Journal:  Oncogene       Date:  2000-12-27       Impact factor: 9.867

7.  Increased ionizing radiation sensitivity and genomic instability in the absence of histone H2AX.

Authors:  Craig H Bassing; Katrin F Chua; JoAnn Sekiguchi; Heikyung Suh; Scott R Whitlow; James C Fleming; Brianna C Monroe; David N Ciccone; Catherine Yan; Katerina Vlasakova; David M Livingston; David O Ferguson; Ralph Scully; Frederick W Alt
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

8.  Inhibition of constitutive STAT3 activity sensitizes resistant non-Hodgkin's lymphoma and multiple myeloma to chemotherapeutic drug-mediated apoptosis.

Authors:  Steve Alas; Benjamin Bonavida
Journal:  Clin Cancer Res       Date:  2003-01       Impact factor: 12.531

9.  DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation.

Authors:  Christopher J Bakkenist; Michael B Kastan
Journal:  Nature       Date:  2003-01-30       Impact factor: 49.962

Review 10.  STATs in cancer inflammation and immunity: a leading role for STAT3.

Authors:  Hua Yu; Drew Pardoll; Richard Jove
Journal:  Nat Rev Cancer       Date:  2009-11       Impact factor: 60.716

View more
  51 in total

1.  Dysregulated miR-34a-SIRT1-acetyl p65 axis is a potential mediator of immune activation in the colon during chronic simian immunodeficiency virus infection of rhesus macaques.

Authors:  Mahesh Mohan; Vinay Kumar; Andrew A Lackner; Xavier Alvarez
Journal:  J Immunol       Date:  2014-12-01       Impact factor: 5.422

2.  STAT3 interrupts ATR-Chk1 signaling to allow oncovirus-mediated cell proliferation.

Authors:  Siva Koganti; Joyce Hui-Yuen; Shane McAllister; Benjamin Gardner; Friedrich Grasser; Umaimainthan Palendira; Stuart G Tangye; Alexandra F Freeman; Sumita Bhaduri-McIntosh
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-17       Impact factor: 11.205

3.  Withaferin A inhibits expression of ataxia telangiectasia and Rad3-related kinase and enhances sensitivity of human breast cancer cells to cisplatin.

Authors:  Eun-Ryeong Hahm; Joomin Lee; Terric Abella; Shivendra V Singh
Journal:  Mol Carcinog       Date:  2019-08-22       Impact factor: 4.784

4.  Inhibition of STAT3 with the Generation 2.5 Antisense Oligonucleotide, AZD9150, Decreases Neuroblastoma Tumorigenicity and Increases Chemosensitivity.

Authors:  Seiichi Odate; Veronica Veschi; Shuang Yan; Norris Lam; Richard Woessner; Carol J Thiele
Journal:  Clin Cancer Res       Date:  2016-10-19       Impact factor: 12.531

5.  Cancer Tendency in a Patient with ZNF341 Deficiency.

Authors:  Sukru Cekic; Julia Maria Hartberger; Stefanie Frey-Jakobs; Huzeyfe Huriyet; Melika Bektas Hortoglu; Johanna Charlotte Neubauer; Yasin Karali; Candan Demiroz Abakay; Ozlem Saraydaroglu; Tolga Cavas; Bodo Grimbacher; Sara Sebnem Kilic
Journal:  J Clin Immunol       Date:  2020-01-24       Impact factor: 8.317

6.  Loss of PIDD limits NF-κB activation and cytokine production but not cell survival or transformation after DNA damage.

Authors:  F J Bock; G Krumschnabel; C Manzl; L Peintner; M C Tanzer; N Hermann-Kleiter; G Baier; L Llacuna; J Yelamos; A Villunger
Journal:  Cell Death Differ       Date:  2012-12-14       Impact factor: 15.828

Review 7.  Oxidative stress and myocardial injury in the diabetic heart.

Authors:  David M Ansley; Baohua Wang
Journal:  J Pathol       Date:  2013-01       Impact factor: 7.996

Review 8.  Biochemical Aspects of PD-L1 Regulation in Cancer Immunotherapy.

Authors:  Jinfang Zhang; Fabin Dang; Junming Ren; Wenyi Wei
Journal:  Trends Biochem Sci       Date:  2018-10-01       Impact factor: 13.807

9.  INPP4B-mediated DNA repair pathway confers resistance to chemotherapy in acute myeloid leukemia.

Authors:  Ping Wang; Dan Ma; Jishi Wang; Qin Fang; Rui Gao; Weibing Wu; Lu Cao; Xiuying Hu; Jiangyuan Zhao; Yan Li
Journal:  Tumour Biol       Date:  2016-06-24

Review 10.  Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution.

Authors:  Uddalak Bharadwaj; Moses M Kasembeli; Prema Robinson; David J Tweardy
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.